Author: Robin Franklin; Adam Young; Bjoern Neumann; Rocio Fernandez; Alexis Joannides; Amir Reyahi; Yorgo Modis
Title: Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19 Document date: 2020_4_10
ID: nd5r4yt4_21
Snippet: If the MMR vaccine provides protection against SARS-CoV-2, as the structural biology suggests, then one would predict a correlation between MMR vaccine coverage and age (and sex)-associated disease profiles of COVID-19. To test this prediction, we examined data from Italy, Spain and Germany, the three European countries with the highest number of reported Covid-19 cases at present. Historic vaccination schedules or recommendations for these count.....
Document: If the MMR vaccine provides protection against SARS-CoV-2, as the structural biology suggests, then one would predict a correlation between MMR vaccine coverage and age (and sex)-associated disease profiles of COVID-19. To test this prediction, we examined data from Italy, Spain and Germany, the three European countries with the highest number of reported Covid-19 cases at present. Historic vaccination schedules or recommendations for these countries were identified from relevant bodies and the literature [Vaccination schedules in Spain, 2019; STIKO, Germany, 2020; Filia, 2003 Estimated average national immunisation coverages with a measles-containing vaccine in the studied countries ranged within 57-97% in Germany (1980 ( ), 63-96% in Spain (1981 , and 53-89% in Italy (1990 Italy ( -2018 . For a rubella-containing vaccine these ranges were the same as for a measlescontaining vaccine in Italy and Spain, and for Germany it was 87-97% Age-adjusted case-fatality risk related to Covid-19 disease increases with age in all countries. It has ranged within 0-10.1%, 0-21.5%, and 0-24% among females and 0-27.3%, 0-32.9%, and 0-30.8% among males, in Germany, Spain and Italy, respectively. In males, the age groups from which casefatality risk started to be over 1% was 70-79, 50-59, 40-49 in Germany, Spain and Italy respectively. In females these age groups were 60-69 in Italy and Spain, and 70-79 in Germany (Fig. 4) .
Search related documents:
Co phrase search for related documents- age adjust and national immunisation: 1
- age disease increase and case fatality: 1, 2
- age disease increase and disease increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- age group and case fatality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- age group and case fatality risk: 1, 2, 3, 4, 5
- age group and casefatality risk: 1
- age group and disease increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- age group and disease profile: 1, 2, 3, 4, 5, 6, 7, 8, 9
- age group and european country: 1, 2, 3
- age group and high number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- age group and MMR vaccine: 1
- age group and national immunisation: 1, 2
- age group and national immunisation coverage: 1
- age group and prediction test: 1
- age group and relevant body: 1
- age group and report case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- age group and SARS protection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- age group and SARS protection provide: 1
- age group and study country: 1, 2, 3, 4, 5, 6, 7, 8, 9
Co phrase search for related documents, hyperlinks ordered by date